CME: Preventing group B streptococcal infections with targeted therapy

Since the CDC recommendations have been put into practice, we've seen a dramatic decline in early-onset neonatal GBS infections. But an expert in the field discusses several unresolved issues and emphasizes the need for continued vigilance to keep the disease under control.

© 2023 MJH Life Sciences

All rights reserved.